Succinylcholine is a paralytic drug used to induce muscle relaxation and short-term paralysis, usually to facilitate tracheal intubation. The two manufacturers are now able to manufacture enough succinylcholine to meet market demands.
This is a positive development for patients and physicians, considering an April 2011 ASA survey on drug shortages found that 47.6 percent of respondents were experiencing a shortage of succinylcholine.
Read the ASA release on succinylcholine.
Related Articles on Anesthesia:
Anesthesiologist Dr. Marshall Joins Joins North Dakota’s Medcenter One
Florida Anesthesiologists Launch National Consulting Firm
Pennsylvania Anesthesiologist Pleads Guilty to Tax Case in Federal Court
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
